Back to Results

Picard Medical Inc (PMI)

Picard Medical Inc. is a healthcare equipment and supplies company focused on medical device development, manufacturing, and commercialization. Through its subsidiaries, the company designs, produces, markets, and sells device products, including SynCardia TAH, an artificial heart intended for patients with advanced heart failure when the human heart has failed. Picard Medical operates in the United States, Europe, and other international markets. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical operates as a subsidiary of Hunniwell Picard I, LLC, and its common stock is listed on the NYSE under the ticker PMI.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-PMI
$0.17
56.0% Upside
Bargain
—
—
—
Weak
—
—
—
0.0%
September 21, 2026
-0.4x
-8.0x
2.1x
11.608 M
14.761 M
21.4%
42.8%
-15.7
—
61.0%
Send a message
Valuation • Fair Value

Picard Medical Inc (NYSE-PMI) Fair Value by Valuation Model

Compare the primary fair value estimate for Picard Medical Inc (NYSE-PMI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.17

Estimated upside of 56.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.15

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$0.22

Earnings power value estimate.

Comps Fair Value

$0.18

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Picard Medical Inc (NYSE-PMI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Picard Medical Inc (NYSE-PMI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

5.47 M

Current operating scale indicator.

Revenue Forecast

5.5 M

Forward revenue estimate.

EBITDA

-14.355 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Picard Medical Inc (NYSE-PMI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Picard Medical Inc (NYSE-PMI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

33.00

Higher caution zone on this screen.

Altman Z-Score

-15.7

Lower score that deserves closer risk review.

FCF / Net Income

61.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Picard Medical Inc (NYSE-PMI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Picard Medical Inc (NYSE-PMI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 21, 2026

Days to Earnings

62

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Picard Medical Inc (NYSE-PMI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Picard Medical Inc (NYSE-PMI) Stock Forecast & Technical Outlook

Review Picard Medical Inc (NYSE-PMI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Picard Medical Inc (NYSE-PMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Picard Medical Inc (NYSE-PMI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Picard Medical Inc (NYSE-PMI) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

Picard Medical Inc (NYSE-PMI) Stock FAQ

Quick answers about Picard Medical Inc (NYSE-PMI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.17
Estimated upside 56.0%
Valuation Rating
Undervalued
Estimated upside of 56.0%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Picard Medical Inc (NYSE-PMI) is $0.17. This implies an estimated upside of 56.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 56.0% versus the current market price.

An analyst price target for Picard Medical Inc (NYSE-PMI) is not currently available in the latest data file.

The current financial health read for Picard Medical Inc (NYSE-PMI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Picard Medical Inc (NYSE-PMI) is September 21, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Picard Medical Inc (NYSE-PMI) is -0.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Picard Medical Inc is 11.608 M.

The current enterprise value listed for Picard Medical Inc is 14.761 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Picard Medical Inc is NYSE-PMI, and the stock is listed on NYSE.

Picard Medical Inc (NYSE-PMI) is listed on NYSE.

The current debt-to-total-capital ratio listed for Picard Medical Inc is 21.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Picard Medical Inc is 42.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks on NYSE View more

Abbott Laboratories (ABT) Abbott Laboratories (ABT)
Stryker Corporation (SYK) Stryker Corporation (SYK)
Medtronic PLC (MDT) Medtronic PLC (MDT)
Boston Scientific Corp (BSX) Boston Scientific Corp (BSX)
Edwards Lifesciences Corp (EW) Edwards Lifesciences Corp (EW)
Becton Dickinson and Co (BDX) Becton Dickinson and Co (BDX)
Alcon AG (ALC) Alcon AG (ALC)
ResMed Inc (RMD) ResMed Inc (RMD)
Koninklijke Philips NV ADR (PHG) Koninklijke Philips NV ADR (PHG)
STERIS plc (STE) STERIS plc (STE)
Zimmer Biomet Holdings Inc (ZBH) Zimmer Biomet Holdings Inc (ZBH)
Solventum Corp (SOLV) Solventum Corp (SOLV)
Smith & Nephew SNATS Inc (SNN) Smith & Nephew SNATS Inc (SNN)
Penumbra Inc (PEN) Penumbra Inc (PEN)
Baxter International Inc (BAX) Baxter International Inc (BAX)
Globus Medical (GMED) Globus Medical (GMED)
Glaukos Corp (GKOS) Glaukos Corp (GKOS)
Teleflex Incorporated (TFX) Teleflex Incorporated (TFX)
Bausch + Lomb Corp (BLCO) Bausch + Lomb Corp (BLCO)
Envista Holdings Corp (NVST) Envista Holdings Corp (NVST)
Haemonetics Corporation (HAE) Haemonetics Corporation (HAE)
Integer Holdings Corp (ITGR) Integer Holdings Corp (ITGR)
Butterfly Network, Inc (BFLY) Butterfly Network, Inc (BFLY)
Enovis Corp (ENOV) Enovis Corp (ENOV)